Try our beta test site
165 studies found for:    Open Studies | "Anemia, Sickle Cell"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Anemia, Sickle Cell"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell Disease
Condition: Anemia, Sickle Cell
Interventions: Drug: Rivipansel;   Other: Placebo
2 Recruiting Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease
Condition: Anemia, Sickle Cell
Intervention: Behavioral: Cogmed RM
3 Not yet recruiting A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients
Condition: Anemia, Sickle Cell
Interventions: Drug: SANGUINATE 320 mg/kg;   Drug: Normal Saline
4 Recruiting Study of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive Crisis
Condition: Anemia, Sickle Cell
Interventions: Drug: SANGUINATE;   Drug: Placebo
5 Recruiting Sickle Cell Disease Biofluid Chip Technology (SCD BioChip)
Condition: Sickle Cell Disease
Intervention: Other: SCD Group
6 Recruiting SMART Mobile Application Technology Utilization in the Treatment of Sickle Cell Disease Post Day Hospital Discharge
Condition: Sickle Cell Disease
Intervention: Device: SMART app
7 Not yet recruiting Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease
Condition: Sickle Cell Disease
Intervention: Other: telephone interview
8 Recruiting Cardiovascular Complications of Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Procedure: MRI, Transthoracic Echocardiography, tonometry, EKG
9 Recruiting Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: CD34 selected T-cell depleted allogeneic SCT
10 Recruiting ElectroNic Hydroxyurea AdhereNCE: A Strategy to Improve Hydroxyurea Adherence in Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Behavioral: Mobile DOT
11 Recruiting Screening Patients With Sickle Cell Disease for Kidney Damage
Condition: Sickle Cell Disease
Intervention:
12 Recruiting Oxygen Therapy and Pregnancy in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Device: oxygen therapy
13 Not yet recruiting Omega-3 Fatty Acids in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: SCD-Omegatex™
14 Recruiting Survey in a Population of Sickle Cell Disease Patients to Evaluate the Transition Between the Queen Fabiola Children Hospital and the CHU Brugmann Hospital, and the Quality of the Hospital Care Within the CHU Brugmann Hospital.
Condition: Sickle Cell Disease
Intervention: Other: Survey
15 Recruiting Stem Cell Gene Therapy for Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Genetic: βAS3-FB vector transduced BM CD34+ cells
16 Recruiting The Role of Endothelin-1 in Sickle Cell Disease
Condition: Sickle Cell Anemia
Interventions: Drug: Ambrisentan;   Drug: Placebo
17 Recruiting Cerebrovascular Reserve Measurements in Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Acetazolamide
18 Not yet recruiting Improving Sickle Cell Disease (SCD) Care Using Web-based Guidelines
Condition: Sickle Cell Disease
Intervention:
19 Not yet recruiting Myeloablative Conditioning and Haplo AlloSCT for Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Defibrotide
20 Recruiting Natural History of Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.